131 related articles for article (PubMed ID: 7932081)
1. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Alder J; Hutch T; Meulbroek JA; Clement JC
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
3. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
Araujo FG; Prokocimer P; Lin T; Remington JS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
[TBL] [Abstract][Full Text] [Related]
4. Activity of minocycline against Toxoplasma gondii infection in mice.
Chang HR; Comte R; Piguet PF; Pechère JC
J Antimicrob Chemother; 1991 May; 27(5):639-45. PubMed ID: 1885421
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
6. Minocycline in the chemotherapy of murine toxoplasmosis.
Tabbara KF; Sakuragi S; O'Connor GR
Parasitology; 1982 Apr; 84(Pt 2):297-302. PubMed ID: 7070843
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
8. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Brun-Pascaud M; Chau F; Derouin F; Girard PM
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
[TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii.
Abugri DA; Witola WH; Russell AE; Troy RM
Chem Biol Drug Des; 2018 Jan; 91(1):194-201. PubMed ID: 28696589
[TBL] [Abstract][Full Text] [Related]
11. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
Xiang X; Ke OY; Zhang Z
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
Lescano SA; Amato Neto V; Chieffi PP; Bezerra RC; Gakiya E; Ferreira CS; Braz LM
Rev Soc Bras Med Trop; 2004; 37(6):460-2. PubMed ID: 15765594
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii.
Olliaro P; Gorini G; Jabes D; Regazzetti A; Rossi R; Marchetti A; Tinelli C; Della Bruna C
J Antimicrob Chemother; 1994 Nov; 34(5):649-57. PubMed ID: 7706160
[TBL] [Abstract][Full Text] [Related]
15. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
Aguirre-Cruz L; Velasco O; Sotelo J
J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
[TBL] [Abstract][Full Text] [Related]
16. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.
Nguyen BT; Stadtsbaeder S
Br J Pharmacol; 1983 Aug; 79(4):923-8. PubMed ID: 6606459
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
Seah SK
J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.
Derouin F; Caroff B; Chau F; Prokocimer P; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Dec; 36(12):2852-5. PubMed ID: 1482160
[TBL] [Abstract][Full Text] [Related]
20. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
Mahmoud MS
J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
